Vaccination

Less than 20% of eligible children in the United States have received a first dose of COVID-19 vaccine, and progress has slowed in the last 2 weeks, according the AAP.

Although vaccination is an effective strategy for COVID-19 prevention, its effectiveness may be reduced in patients with multiple myeloma, likely because of immunosuppression due to the disease process and related therapy.

A vast majority of patients with acute myeloid leukemia and myelodysplastic syndrome converted to seropositivity after two COVID-19 vaccine doses, according to a study presented at ASH Annual Meeting and Exposition.

Nearly one in six patients with hematologic disorders had a negative COVID-19 vaccination-related antibody response, according to results of a prospective, observational single-center study presented at ASH Annual Meeting and Exposition.

In this video from ACR Convergence 2021, Kathryn Dao, MD, discussed multiple presentations that investigated questions rheumatologists have had about COVID-19 since the pandemic began.

COVID-19 vaccination rates differ significantly among people with HIV, researchers found.

Messages about safety and how vaccines protect infants motivate pregnant women to get immunized, especially when they are delivered by trusted health care workers, according to a survey published in Women’s Health Issues.

Brigham and Women’s Hospital will soon commence a clinical trial to test the first nasally administered treatment intended to arrest the progression of Alzheimer’s disease, according to a press release.

Despite large strides in vaccination, about 2.9 million children in India were not vaccinated in 2016, a study found.

The ability of COVID-19 to cause cardiac injury and myocarditis has been well documented since the pandemic began, and data continue to accumulate.